SI2552461T1 - Tetratiomolibdat za uporabo pri zdravljenju ishemične-reperfuzijske poškodbe glave ali možganov - Google Patents
Tetratiomolibdat za uporabo pri zdravljenju ishemične-reperfuzijske poškodbe glave ali možganovInfo
- Publication number
- SI2552461T1 SI2552461T1 SI201130380T SI201130380T SI2552461T1 SI 2552461 T1 SI2552461 T1 SI 2552461T1 SI 201130380 T SI201130380 T SI 201130380T SI 201130380 T SI201130380 T SI 201130380T SI 2552461 T1 SI2552461 T1 SI 2552461T1
- Authority
- SI
- Slovenia
- Prior art keywords
- tetrathiomolybdate
- ischemia
- brain
- head
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1005394.0A GB201005394D0 (en) | 2010-03-30 | 2010-03-30 | Therapy |
| PCT/GB2011/050653 WO2011121354A1 (en) | 2010-03-30 | 2011-03-30 | The therapeutic use of tetrathiomolybdate |
| EP11716626.4A EP2552461B1 (en) | 2010-03-30 | 2011-03-30 | Tetrathiomolybdate for use in the treatment of ischemia-reperfusion injury of the head or brain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2552461T1 true SI2552461T1 (sl) | 2015-03-31 |
Family
ID=42228650
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201130380T SI2552461T1 (sl) | 2010-03-30 | 2011-03-30 | Tetratiomolibdat za uporabo pri zdravljenju ishemične-reperfuzijske poškodbe glave ali možganov |
| SI201130385T SI2556834T1 (sl) | 2010-03-30 | 2011-03-30 | Tetratiomolibdat za uporabo pri zdravljenju ishemične-reperfuzijske poškodbe srca |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201130385T SI2556834T1 (sl) | 2010-03-30 | 2011-03-30 | Tetratiomolibdat za uporabo pri zdravljenju ishemične-reperfuzijske poškodbe srca |
Country Status (12)
| Country | Link |
|---|---|
| EP (3) | EP2552461B1 (sl) |
| JP (2) | JP5674917B2 (sl) |
| CN (1) | CN103096903A (sl) |
| BR (1) | BR112012024704A8 (sl) |
| DK (3) | DK2556834T3 (sl) |
| ES (3) | ES2573809T3 (sl) |
| GB (1) | GB201005394D0 (sl) |
| HU (1) | HUE024155T2 (sl) |
| PL (2) | PL2552461T3 (sl) |
| PT (2) | PT2552461E (sl) |
| SI (2) | SI2552461T1 (sl) |
| WO (1) | WO2011121354A1 (sl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10478455B2 (en) | 2010-03-30 | 2019-11-19 | Ucl Business Ltd | Therapeutic use of tetrathiomolybdate |
| EP2578221A1 (en) * | 2011-10-04 | 2013-04-10 | Magnus Intellectual Property Ltd. | The therapeutic use of tetrathiomolybdate |
| WO2017019892A1 (en) * | 2015-07-28 | 2017-02-02 | Insmed Incorporated | Compositions comprising copper chelators and methods of use thereof for treating vasculopathies |
| DK3529231T3 (da) | 2016-10-21 | 2021-05-31 | Ucl Business Ltd | Krystallinsk diethylamintetrathiomolybdat og farmaceutiske anvendelser deraf |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1107795E (pt) * | 1998-09-04 | 2003-04-30 | Univ Michigan | Tiomolibdato associado com pelo menos um hidrato de carbono e o seu uso para evitar ou tratar doencas caracterizadas por uma vascularizacao tais como cancro degeneracao macular do tipo humido artrite reumatoide |
| US6703050B1 (en) * | 1998-09-04 | 2004-03-09 | The Regents Of The University Of Michigan | Methods and compositions for the prevention or treatment of cancer |
| WO2003075910A1 (en) * | 2002-03-08 | 2003-09-18 | Protemix Corporation Limited | Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure |
| US6855340B2 (en) * | 2002-05-24 | 2005-02-15 | Regents Of The University Of Michigan | Copper lowering treatment of inflammatory and fibrotic diseases |
| AU2003214725A1 (en) * | 2002-08-20 | 2004-03-11 | Protemix Corporation Limited | Preventing and/or treating cardiovascular disease and/or associated heart failure |
| US7618615B2 (en) * | 2004-08-13 | 2009-11-17 | Healthpartners Research Foundation | Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia |
| WO2007084818A2 (en) * | 2006-01-10 | 2007-07-26 | Pipex, Inc. | Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| WO2008100653A2 (en) * | 2007-01-08 | 2008-08-21 | The Regents Of The University Of Michigan | Copper lowering treatment of cardiac disease |
-
2010
- 2010-03-30 GB GBGB1005394.0A patent/GB201005394D0/en not_active Ceased
-
2011
- 2011-03-30 SI SI201130380T patent/SI2552461T1/sl unknown
- 2011-03-30 EP EP11716626.4A patent/EP2552461B1/en active Active
- 2011-03-30 DK DK12189630.2T patent/DK2556834T3/en active
- 2011-03-30 PL PL11716626T patent/PL2552461T3/pl unknown
- 2011-03-30 SI SI201130385T patent/SI2556834T1/sl unknown
- 2011-03-30 CN CN2011800168365A patent/CN103096903A/zh active Pending
- 2011-03-30 EP EP14194820.8A patent/EP2842562B1/en active Active
- 2011-03-30 HU HUE12189630A patent/HUE024155T2/en unknown
- 2011-03-30 PT PT117166264T patent/PT2552461E/pt unknown
- 2011-03-30 DK DK14194820.8T patent/DK2842562T3/en active
- 2011-03-30 ES ES14194820.8T patent/ES2573809T3/es active Active
- 2011-03-30 PL PL12189630T patent/PL2556834T3/pl unknown
- 2011-03-30 WO PCT/GB2011/050653 patent/WO2011121354A1/en active Application Filing
- 2011-03-30 ES ES11716626.4T patent/ES2529115T3/es active Active
- 2011-03-30 EP EP12189630.2A patent/EP2556834B1/en active Active
- 2011-03-30 BR BR112012024704A patent/BR112012024704A8/pt not_active Application Discontinuation
- 2011-03-30 ES ES12189630.2T patent/ES2529225T3/es active Active
- 2011-03-30 DK DK11716626.4T patent/DK2552461T3/en active
- 2011-03-30 JP JP2013501947A patent/JP5674917B2/ja active Active
- 2011-03-30 PT PT121896302T patent/PT2556834E/pt unknown
-
2014
- 2014-12-22 JP JP2014258628A patent/JP6038867B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012024704A8 (pt) | 2021-03-23 |
| EP2842562A1 (en) | 2015-03-04 |
| EP2552461A1 (en) | 2013-02-06 |
| JP2015057450A (ja) | 2015-03-26 |
| HUE024155T2 (en) | 2016-02-29 |
| EP2552461B1 (en) | 2014-12-17 |
| WO2011121354A1 (en) | 2011-10-06 |
| CN103096903A (zh) | 2013-05-08 |
| EP2556834B1 (en) | 2014-11-26 |
| EP2556834A1 (en) | 2013-02-13 |
| DK2552461T3 (en) | 2015-02-09 |
| EP2842562B1 (en) | 2016-04-27 |
| ES2529225T3 (es) | 2015-02-18 |
| GB201005394D0 (en) | 2010-05-12 |
| PL2556834T3 (pl) | 2015-04-30 |
| SI2556834T1 (sl) | 2015-05-29 |
| DK2842562T3 (en) | 2016-06-06 |
| ES2573809T3 (es) | 2016-06-10 |
| JP5674917B2 (ja) | 2015-02-25 |
| PT2556834E (pt) | 2015-02-10 |
| PT2552461E (pt) | 2015-02-10 |
| PL2552461T3 (pl) | 2015-04-30 |
| JP6038867B2 (ja) | 2016-12-07 |
| JP2013523709A (ja) | 2013-06-17 |
| ES2529115T3 (es) | 2015-02-17 |
| DK2556834T3 (en) | 2015-02-09 |
| BR112012024704A2 (pt) | 2021-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20180659T1 (hr) | Disperzija amorfne krutine, namijenjena upotrebi u liječenju raka na mozgu | |
| EP2575816A4 (en) | COMBINATION THERAPY FOR HAIR DRESSES | |
| HK1209424A1 (en) | Oxabicycloheptanes and oxabicycloheptenes for the treatment of reperfusion injury | |
| EP2616094A4 (en) | TREATMENT OF BRAIN INJURIES THROUGH IMPORTS | |
| HUS2000020I1 (hu) | Ciklezonid a légúti betegségek kezelésére lovaknál | |
| HK1201045A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| HK1203054A1 (en) | Dinuceloside polyphosphates for the treatment of pain | |
| PL2872176T3 (pl) | Karboranyloporfiryny do stosowania w leczeniu raka | |
| PT2552461E (pt) | Tetratiomolibdato para utilização no tratamento da lesão de isquémia-reperfusão da cabeça ou do cérebro | |
| EP2616485A4 (en) | STEPPED DEVELOPED PEPTIDE FOR THE TREATMENT OF BRAIN INJURIES | |
| HK1214771A1 (zh) | 用於治療皮膚病的製劑 | |
| HRP20211496T8 (hr) | Uređaji za liječenje ozljeda kože | |
| PL2819655T3 (pl) | Modafinil do stosowania w leczeniu uzależnionych od kokainy | |
| EP2588866A4 (en) | DIAGNOSIS AND TREATMENT OF BRAIN TUMORS | |
| ZA201402477B (en) | Compounds for use in the treatment of alzheimer's disease | |
| EP2531186A4 (en) | TREATMENT OF HAIR DRESSES | |
| EP2892618A4 (en) | METHOD FOR SELECTIVELY INHIBITING THE ACTIVITY OF ACAT1 IN THE TREATMENT OF MORBUS ALZHEIMER | |
| GB201001659D0 (en) | Body treatment product | |
| GB201001913D0 (en) | Skin treatment apparatus |